Morgan Stanley Initiates Coverage On Biohaven with Overweight Rating, Announces Price Target of $58
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has initiated coverage on Biohaven (NYSE:BHVN) with an Overweight rating and a price target of $58, as announced by analyst Terence Flynn.
July 24, 2024 | 9:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley has initiated coverage on Biohaven with an Overweight rating and a price target of $58, indicating a positive outlook for the stock.
The initiation of coverage by a major financial institution like Morgan Stanley with an Overweight rating and a specific price target of $58 is a strong positive signal for investors. This could lead to increased investor confidence and buying activity in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100